Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  INC Research Holdings Inc    

INC RESEARCH HOLDINGS INC
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of INC Research Holdings, Inc. (INCR)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 06:43pm CEST

NEW YORK, Nov. 10, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ: INCR). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/incr.

The investigation concerns whether INC Research and certain of its officers and/or directors have violated Sections federal securities laws.

On August 1, 2017, INC Research and inVentiv Health, Inc. ("inVentiv Health") announced the completion of a merger between the two companies. On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health. The Company's combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses. Following this news, INC Research stock dropped $16.35 per share, or 28.43%, to close at $41.15 on November 9, 2017.

If you are aware of any facts relating to this investigation, or purchased shares of INC Research, you can assist this investigation by visiting the firm's site: www.bgandg.com/incr. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-inc-research-holdings-inc-incr-300553934.html

SOURCE Bronstein, Gewirtz & Grossman, LLC


© PRNewswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INC RESEARCH HOLDINGS INC
06/13SYNEOS HEALTH : to lay off 98 amid changing business needs
AQ
06/08SYNEOS HEALTH : Consulting Releases 10th Annual Biopharmaceutical Dealmakers Sur..
AQ
06/06SYNEOS HEALTH : Consulting Releases 10th Annual Biopharmaceutical Dealmakers Sur..
AQ
06/06SYNEOS HEALTH : to Present Actionable Commercial Insights Designed for Biopharma..
AQ
06/05SYNEOS HEALTH : Consulting Releases 10th Annual Biopharmaceutical Dealmakers Sur..
AQ
06/05Syneos Health to Present Actionable Commercial Insights Designed for Biopharm..
GL
05/25SYNEOS HEALTH, INC. : Change in Directors or Principal Officers, Submission of M..
AQ
05/21Syneos Health to Present at Upcoming Investors Conferences
GL
05/15SYNEOS HEALTH : Promotes Jason Meggs to Chief Financial Officer
AQ
05/10INC. (NASDAQ : INCR) Files An 8-K Other Events
AQ
More news
News from SeekingAlpha
01/03INC Research CFO exiting post at April's end 
2017INC Research Holdings 2017 Q3 - Results - Earnings Call Slides 
2017INC Research's (INCR) CEO Alistair MacDonald on Q3 2017 Results - Earnings Ca.. 
2017Midday Gainers / Losers 
2017INC Research misses by $0.08, misses on revenue